Insights

Growing Expansion BioVectra has recently expanded its manufacturing capacity with a new 36,000 square-foot facility in Prince Edward Island and plans for additional facilities in Nova Scotia, indicating increased production capabilities and a strong growth trajectory ideal for partnerships in biologics and small molecule manufacturing.

Innovative Technologies The integration of advanced sequence optimization technologies like Revolution Biomanufacturing positions BioVectra as a leader in reliable, risk-reduced biomanufacturing, presenting opportunities to collaborate on cutting-edge drug development projects.

Award-Winning Reputation Receiving the 2025 CDMO Leadership Award highlights BioVectra’s recognized leadership quality in biologics, making it an attractive partner for clients seeking reputable contract development and manufacturing services in high-demand biologics markets.

Financial Growth With a revenue range of $50M to $100M and a recent infusion of $40M funding, BioVectra demonstrates financial stability and investment potential, making it suitable for strategic collaborations and long-term projects in biologics and specialty molecules.

Market Versatility BioVectra’s expertise spans biologics, synthetic small molecules, mRNA, and highly potent APIs, offering multiple avenues for business development across diverse high-growth biotech and pharmaceutical sectors worldwide.

BIOVECTRA Tech Stack

BIOVECTRA uses 8 technology products and services including Fusion Ads, Blackline, Modernizr, and more. Explore BIOVECTRA's tech stack below.

  • Fusion Ads
    Advertising
  • Blackline
    Corporate Performance Management
  • Modernizr
    Javascript Libraries
  • Ceridian Payroll
    Payroll Management And Benefits Administration
  • Cloudflare Bot Management
    Security
  • Minitab
    Visualisation Software
  • Autoptimize
    Web Platform Extensions
  • Ivory Search
    Web Platform Extensions

Media & News

BIOVECTRA's Email Address Formats

BIOVECTRA uses at least 1 format(s):
BIOVECTRA Email FormatsExamplePercentage
FLast@biovectra.comJDoe@biovectra.com
97%
FiLast@biovectra.comJoDoe@biovectra.com
1%
FMiddleLast@biovectra.comJMichaelDoe@biovectra.com
1%
LFirst@biovectra.comDJohn@biovectra.com
1%

Frequently Asked Questions

Where is BIOVECTRA's headquarters located?

Minus sign iconPlus sign icon
BIOVECTRA's main headquarters is located at 11 Aviation Avenue Charlottetown, Prince Edward Island c1e 0a1 Canada. The company has employees across 2 continents, including North AmericaEurope.

What is BIOVECTRA's phone number?

Minus sign iconPlus sign icon
You can contact BIOVECTRA's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BIOVECTRA's official website and social media links?

Minus sign iconPlus sign icon
BIOVECTRA's official website is biovectra.com and has social profiles on LinkedIn.

How much revenue does BIOVECTRA generate?

Minus sign iconPlus sign icon
As of April 2026, BIOVECTRA's annual revenue is estimated to be $20M.

What is BIOVECTRA's SIC code NAICS code?

Minus sign iconPlus sign icon
BIOVECTRA's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BIOVECTRA have currently?

Minus sign iconPlus sign icon
As of April 2026, BIOVECTRA has approximately 536 employees across 2 continents, including North AmericaEurope. Key team members include Chief Operating Officer: T. D.Chief Commercial Officer: H. D.Vice President & General Manager, Biologics: S. D.. Explore BIOVECTRA's employee directory with LeadIQ.

What industry does BIOVECTRA belong to?

Minus sign iconPlus sign icon
BIOVECTRA operates in the Biotechnology Research industry.

What technology does BIOVECTRA use?

Minus sign iconPlus sign icon
BIOVECTRA's tech stack includes Fusion AdsBlacklineModernizrCeridian PayrollCloudflare Bot ManagementMinitabAutoptimizeIvory Search.

What is BIOVECTRA's email format?

Minus sign iconPlus sign icon
BIOVECTRA's email format typically follows the pattern of FLast@biovectra.com. Find more BIOVECTRA email formats with LeadIQ.

How much funding has BIOVECTRA raised to date?

Minus sign iconPlus sign icon
As of April 2026, BIOVECTRA has raised $40M in funding. The last funding round occurred on Mar 03, 2019 for $38M.

When was BIOVECTRA founded?

Minus sign iconPlus sign icon
BIOVECTRA was founded in 1970.

BIOVECTRA

Biotechnology ResearchPrince Edward Island, Canada501-1000 Employees

Expertise in both microbial fermentation and chemical synthesis allows us to tackle today’s development pipeline’s increasingly complex molecules. In fact, we thrive on the vexing challenges few CDMOs would have either the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision a reality, is at the heart of our organization.

We are a forward-thinking, North American CDMO Pharmaceutical company  specializing in clinical-to-commercial scale production capabilities for:
Biologics
Synthetic small molecules 
Fermented small molecules
Highly potent APIs
Bioreagents
mRNA, pDNA, LNP manufacturing
Fill/Finish

Flexibility, creativity, and dedication to process optimization are at the heart of our method and process development as well as quality and compliance efforts. We ensure the programs advance on time and with the highest quality outcomes under our project managers’ leadership.

Section iconCompany Overview

Headquarters
11 Aviation Avenue Charlottetown, Prince Edward Island c1e 0a1 Canada
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1970
Employees
501-1000

Section iconFunding & Financials

  • $40M

    BIOVECTRA has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Mar 03, 2019 in the amount of $38Mas a investment.

  • $50M$100M

    BIOVECTRA's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $40M

    BIOVECTRA has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Mar 03, 2019 in the amount of $38Mas a investment.

  • $50M$100M

    BIOVECTRA's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.